Biotech entity
pharma is the sole category represented across all 1 tracked stories. Maria Dobek is most often covered alongside Janeen Noel Doyle, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Maria Dobek appears in 1 tracked Biotech story from August 9, 2026.
Last mentioned: Aug 9, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Maria Dobek is most often covered alongside Janeen Noel Doyle, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Maria Dobek appears in 1 tracked Biotech story from August 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Maria Dobek. Shared-story counts are live from our verified record — not editorial picks.
Janux Therapeutics’ Q2 revenue of $10.27M fell 46% below consensus, raising concerns about partnership milestone achievements for its T-cell engager programs. The wider EPS loss signals accelerating R&D costs as the company pushes early-stage trials.
Source: MarketBeat · themarketsdaily.com
Maria Dobek is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
